News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Tomovircona, a Novel RNAi-Based Virucide by Silicon Gene Technologies (Shanghai) Co., Ltd., Receives ISO approval

    Patented New ISO Name Approved – December 2025: Triflupyroxazin, A New N-phenylimide Herbicide From Liaoning Cynda Chemical Co., Ltd.

    Patented New ISO Name Approved – December 2025: Amfenamacril, A New Aminocyanoacrylate Fungicide From Jiangsu Pesticide Research Institute Co., Ltd.

    Medicago’s Plant-Based Vaccine Bolstered by GSK Adjuvant Wins First Approval

    adminFebruary 25, 202201.8k views

    Summary : Canada’s Medicago scored a regulatory first after Health Canada approved its plant-based COVID-19 vaccine Covifenz that has been paired with…

    Read more

    Takeda-Backed Biotech Grabs $24 Million for tRNA-Based Therapies

    adminFebruary 25, 202201.9k views

    Summary : hC Bioscience, Inc., a company focused on discovering and developing tRNA-based therapies, announced that it has raised $24 million in…

    Read more

    LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea

    adminFebruary 25, 202201.8k views

    Summary : LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational…

    Read more

    CANbridge Announces Approval of CAN108 for Rare Liver Disease, Alagille Syndrome, Under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone

    adminFebruary 25, 202201.6k views

    Summary : CANbridge Pharmaceuticals, Inc. (“CANbridge”, stock code 1228.HK), a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development…

    Read more

    Biomind Labs Announces DTC Eligibility in the United States

    adminFebruary 24, 202201.9k views

    Summary : Alejandro Antalich, Chief Executive Officer and Director of Biomind Labs, said: “We are pleased to have obtained our DTC eligibility,…

    Read more

    c-LEcta Announces That It Has Reached Agreement to Be Acquired by Kerry Group

    adminFebruary 24, 202201.6k views

    Synopsis : Kerry Group acquires majority of the shares of c-LEcta GmbH. The previous management of c-LEcta remains on board. Acquisition promotes…

    Read more

    American Oncology Network (AON) and VieCure Announce Strategic Collaboration to Accelerate Adoption of Precision Oncology and Personalized Cancer Care

    adminFebruary 24, 202202k views

    Summary : Collaboration offers clinicians access to a state-of-the-art, cloud based oncology decision support platform that fully integrates the latest codified clinical…

    Read more

    Gunze Launches TENALEAF™ Absorbable Adhesion Barrier in Japan

    adminFebruary 24, 202202k views

    Summary : Gunze Limited (Headquarters: Osaka, Japan, President: Toshiyasu Saguchi) [TOKYO: 3002] is pleased to announce that Gunze has obtained medical device…

    Read more

    Lysogene Provides Update on Efficacy, Safety and Timelines of the AAVance Phase 2/3 Clinical Trial with Gene Therapy LYS-SAF302 for the Treatment of MPSIIIA

    adminFebruary 24, 202201.6k views

    Summary : Topline data of the main cohort of AAVance clinical trial expected in Q3 2022 Stabilization or decreased size of white…

    Read more

    Moderna Cleared to Bring RSV Vaccine to Pivotal Phase III Trial

    adminFebruary 24, 202201.6k views

    Summary : Moderna is poised to begin Phase III of its pivotal clinical trial for its candidate vaccine for respiratory syncytial virus…

    Read more

    Posts navigation

    1 … 37 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top